Trial Comparing Treatment Strategies in Dupuytren's Contracture
Status:
Active, not recruiting
Trial end date:
2031-05-31
Target enrollment:
Participant gender:
Summary
Trial is a prospective, randomized, controlled, outcome assessor-blinded, three armed
parallel 1:1:1, multicenter trial. The research objective is to determine, which treatment
strategy 1) primary percutaneous needle fasciotomy (PNF) followed by surgical limited
fasciectomy (LF) in patients who do not respond to PNF, 2) primary collagenase clostridium
histolyticym (CCH) followed by LF in patients who do not respond to CCH or 3) LF as the
primary (and secondary) treatment modality is the most cost-effective in treating Dupuytren´s
contracture.
Phase:
Phase 4
Details
Lead Sponsor:
Tampere University University of Tampere
Collaborators:
Central Hospital of Central Finland Finnish Institute for Health and Welfare Hatanpää Hospital Helsinki University Central Hospital Kuopio University Hospital Medcare Plc National Institute for Health and Welfare, Finland Oulu University Hospital Tampere University Hospital Turku University Hospital